Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
AxoGen (GB:0HKD)
LSE:0HKD
AxoGen (0HKD) Share Price & Analysis
0 Followers
0HKD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.06 - $13.19
Previous Close$8.48
Volume107.00
Average Volume (3M)173.00
Market Cap
$370.07M
Enterprise Value$378.13M
Total Cash (Recent Filing)$37.87M
Total Debt (Recent Filing)$45.93M
Price to Earnings (P/E)-14.6
Beta-0.35
Next Earnings
Aug 02, 2023EPS Estimate
-$0.12Last Dividend Ex-Date
Jan 27, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding42,832,050
10 Day Avg. Volume1
30 Day Avg. Volume173
Standard Deviation0.18
R-Squared0.01
Alpha0.00888
Financial Highlights & Ratios
Price to Book (P/B)3.74
Price to Sales (P/S)23.23
Price to Cash Flow (P/CF)66.80
P/FCF Ratio64.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.62
Enterprise Value/Gross Profit3.30
Enterprise Value/Ebitda-19.28
Forecast
1Y Price Target
$16.00Price Target Upside88.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
AxoGen News
Press ReleasesAxogen to Participate at Jefferies Healthcare Conference
Pre-EarningsAxoGen (AXGN) Q1 Earnings Cheat Sheet
0HKD FAQ
What was AxoGen’s price range in the past 12 months?
AxoGen lowest share price was $8.06 and its highest was $13.19 in the past 12 months.
What is AxoGen’s market cap?
Currently, no data Available
When is AxoGen’s upcoming earnings report date?
AxoGen’s upcoming earnings report date is Aug 02, 2023 which is in 59 days.
How were AxoGen’s earnings last quarter?
AxoGen released its earnings results on May 09, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.142 by $0.042.
Is AxoGen overvalued?
According to Wall Street analysts AxoGen’s price is currently Undervalued.
Does AxoGen pay dividends?
AxoGen pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on AxoGen dividends here
What is AxoGen’s EPS estimate?
AxoGen’s EPS estimate is -$0.12.
How many shares outstanding does AxoGen have?
AxoGen has 42,832,050 shares outstanding.
What happened to AxoGen’s price movement after its last earnings report?
AxoGen reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.142. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AxoGen?
Among the largest hedge funds holding AxoGen’s share is Perceptive Advisors LLC. It holds AxoGen’s shares valued at 13M.
---
AxoGen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.00 (88.61% Upside)
$16.00 (88.61% Upside)
Blogger Sentiment
Neutral
GB:0HKD Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $68.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.16%
12-Months-Change
Fundamentals
Return on Equity
-24.38%
Trailing 12-Months
Asset Growth
-4.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AxoGen
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
---
AxoGen
―
Axsome Therapeutics
―
BioCryst
―
Corvus Pharmaceuticals
―
Eton Pharmaceuticals
―
---